Regulation (EC) No 816/2006 contains provisions for compulsory licenses specifically for the export of pharmaceutical products to countries with public health problems. This applies to all Member States of the European Union (EU).
|Applicable countries||Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Spain, Sweden|
Compulsory licensing provision
Pharmaceutical export provision
|Original publication||17 May 2006|
|Entered into force||29 Jun 2006|
|Latest update||29 Jun 2006|
|Relevant articles||Articles 1-20|